Data as of Jan 26
 -0.01 / -0.27%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

MEI Pharma, Inc. is a oncology company, which focuses on the clinical development of novel small molecules for the treatment of cancer. The company currently focuses on the clinical development of two drug candidates, ME-143 and ME-344. MEI Pharma was founded on December 1, 2000 and is headquartered in San Diego, CA.

Contact Information

MEI Pharma, Inc.
11975 El Camino Real
San Diego California 92130-2541
P:(858) 792-6300
Investor Relations:
(858) 369-7199



Other institutional23.43%
Mutual fund holders23.24%
Individual stakeholders16.43%

Top Executives

Daniel P. GoldPresident, Chief Executive Officer & Director
Thomas M. ZechChief Financial Officer & Secretary
Ofir MorenoVice President-Research & Development
Robert D. MassChief Medical Officer
Kelly PowellVice President-Business Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.